Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation

被引:28
作者
Bakker, Sjoerd F. [1 ]
Dik, Vincent K. [2 ]
Witte, Birgit I. [3 ]
Lips, Paul [4 ]
Roos, Jan C. [5 ]
Van Bodegraven, Adriaan A. [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Gastroenterol & Hepatol, Med Ctr, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[3] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Internal Med, Med Ctr, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Dept Radiol, Med Ctr, Amsterdam, Netherlands
关键词
Crohn's disease; Osteoporosis; Osteopenia; Bone mineral density; INFLAMMATORY-BOWEL-DISEASE; CONTROLLED-TRIAL; SODIUM-FLUORIDE; RISK-FACTORS; OSTEOPOROSIS; PREVENTION; PREVALENCE; METABOLISM; THERAPY;
D O I
10.1016/j.crohns.2012.06.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Decreased bone mineral density (BMD) is common in Crohn's disease (CD) patients. This paper reports on the prevalence of decreased BMD in a referral cohort study of CD-patients next to the change of BMD over time in relation with CD-associated clinical characteristics. Methods: 205 CD patients of a referral hospital were enrolled between januari 1998-January 2010 when measurement of BMD by dual X-ray absorptiometry (DXA) was available. Follow-up DXA scan was performed in subjects with known risk factors besides Crohn indicative for low BMD. Treatment of CD patients was according to a protocol which is comparable to the current (inter)national guidelines. In osteopenic patients, supplemental vitamin D (800 IU) and Calcium (500-1000 mg) were prescribed. Results: Mean BMD at baseline was 0.97 +/- 0.16 gram/cm(2) in lumbar spine and 0.87 +/- 0.12 gram/cm(2) in the total hip. At baseline, higher age and low Body Mass Index (BMI), were negatively correlated with BMD. Eighty-four patients underwent a second BMD assessment with a median interval period of 4 years (IQR 3-6). A mean annual increase of +0.76% (95%CI: -2.63%; +3.87%) in lumbar spine and +0.43% (95%CI: -2.65%; +1.11%) in total hip was observed. Conclusions: Higher age, male sex, low BMI, and a higher age at diagnosis of CD were associated with low BMD. Follow-up of BMD in CD patients showed a contraintuitive small increase of BMD at lumbar spine and total hip in CD patients only using supplemental vitamin D and calcium next to strict treatment of CD. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:377 / 384
页数:8
相关论文
共 33 条
[1]   Osteoporosis in inflammatory bowel disease:: effect of calcium and vitamin D with or without fluoride [J].
Abitbol, V ;
Mary, JY ;
Roux, C ;
Soulés, JC ;
Belaiche, J ;
Dupas, JL ;
Gendre, JP ;
Lerebours, E ;
Chaussade, S .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (05) :919-927
[2]   Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: A case-control cross-sectional study of 113 patients [J].
Andreassen, H ;
Hylander, E ;
Rix, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03) :824-828
[3]   A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease [J].
Bartram, SA ;
Peaston, RT ;
Rawlings, DJ ;
Francis, RM ;
Thompson, NP .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) :1121-1127
[4]   Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease [J].
Bartram, Sarah A. ;
Peaston, Robert T. ;
Rawlings, David ;
Walshaw, David ;
Francis, Roger M. ;
Thompson, Nick P. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (35) :5680-5686
[5]   The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study [J].
Bernstein, CN ;
Blanchard, JF ;
Leslie, W ;
Wajda, A ;
Yu, BN .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) :795-799
[6]   Review article: Osteoporosis and inflammatory bowel disease [J].
Bernstein, CN ;
Leslie, WD .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (09) :941-952
[7]   A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study [J].
Bernstein, CN ;
Seeger, LL ;
Anton, PA ;
Artinian, L ;
Geffrey, S ;
Goodman, W ;
Belin, TR ;
Shanahan, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (05) :777-786
[8]  
Bischoff SC, 1997, AM J GASTROENTEROL, V92, P1157
[9]  
CUMMING RG, 1990, CALCIFIED TISSUE INT, V47, P194
[10]   Longitudinal study of bone mineral density in patients with Crohn's disease [J].
De Jong, DJ ;
Mannaerts, L ;
Van Rossum, LGM ;
Corstens, FHM ;
Naber, AHJ .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (07) :1355-1359